Skip to main content
JAMA internal medicine
Availability and Dissemination of Results From US Food and Drug Administration-Mandated Postapproval Studies for Medical Devices.
Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742.
Notice of Retraction: Sato Y, et al. Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke. Arch Intern Med. 2005;165(15):1743-1748.
Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now.
The Medicalization of Common Conditions.
Announcing a New JAMA Internal Medicine Website.
Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak.
Firearm Violence: A JAMA Internal Medicine Series.
Colorectal Cancer Screening Comparative Effectiveness-Clinical Trials Are Not Always The Answer-Reply.
Women in Medicine and Patient Outcomes: Equal Rights for Better Work?
